Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G et al (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension
HS-10535 has rarely been discussed by investors and may not have contributed much at all to Hansohs valuation, Morgan Stanley analysts wrote in a note, adding that the deal is a de-risking move given the increasingly competitive GLP-1 landscape
Where a statement could otherwise be read as a brand-substantiated fact, attribution language such as "according to the brand," "brand-stated," "brand-reported," or "per the official Terms" identifies it as a brand claim that has not been independently verified by this publication
If you're approved, your personalized prescription is prepared and shipped directly to your door within 1 business dayno pharmacy lines or delays